Outcome of planned pregnancies in systemic lupus erythematosus: A prospective study on 62 pregnancies

British Journal of Rheumatology

Volumn 36, Issue 7, 1997, Pages 772-777

  Le Thi Huong D ^a   Wechsler, B ^a   Vauthier Brouzes, D ^b   Seebacher, J ^b   Lefebvre G ^b   Bletry O ^a   Darbois, Y ^b   Godeau, P ^a   Piette, J C ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b FOCH HOSPITAL   (France)

Author keywords

Antiphospholipid antibodies; Pregnancy; Systemic lupus erythematosus

Indexed keywords

ACETYLSALICYLIC ACID; CORTICOSTEROID; DEXAMETHASONE; HEPARIN; PHOSPHOLIPID ANTIBODY; PREDNISONE;

ANTIPHOSPHOLIPID SYNDROME; ARTICLE; ATRIOVENTRICULAR BLOCK; CESAREAN SECTION; CLINICAL EXAMINATION; DISEASE ACTIVITY; FEMALE; FETUS ECHOGRAPHY; FETUS OUTCOME; FETUS WASTAGE; GROWTH RETARDATION; HUMAN; INDUCED ABORTION; LABORATORY TEST; MAJOR CLINICAL STUDY; NEWBORN INFECTION; PATIENT MONITORING; PREGNANCY; PREMATURE LABOR; PREMATURITY; PRIORITY JOURNAL; PROLIFERATIVE GLOMERULONEPHRITIS; PROSPECTIVE STUDY; PUERPERIUM; RELAPSE; SKIN LUPUS ERYTHEMATOSUS; SPONTANEOUS ABORTION; STILLBIRTH; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOSIS;

ADRENAL CORTEX HORMONES; AGING; ANTI-INFLAMMATORY AGENTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIBODIES, ANTIPHOSPHOLIPID; ASPIRIN; FEMALE; FERTILITY; HUMANS; INCIDENCE; LUPUS ERYTHEMATOSUS, SYSTEMIC; MATERNAL WELFARE; OBSTETRIC LABOR, PREMATURE; PREDNISONE; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; PROGNOSIS; PROSPECTIVE STUDIES; TIME FACTORS;

EID: 0346353779     PISSN: 02637103     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Petri M. Systemic lupus erythematosus and pregnancy. Rheum Dis Clin North Am 1994;20:87-118.
2. Lê Thi Huong D, Wechsler B, Piette JC, Blétry O, Godeau P. Pregnancy and its outcome in systemic lupus erythematosus. Q J Med 1994;87:721-9.
3. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
4. Hughes GRV. Thrombosis, abortion, cerebral disease and lupus anticoagulant. Br Med J 1983;287:1088-9.
5. Harris EN, Gharavi AE, Patel SP, Hughes GRV. Evaluation of the anticardiolipin antibody test: report of an international workshop held 4 April 1986. Clin Exp Immunol 1987;68:215-22.
6. Sibai BM, Caritis SN, Thom E, Klebanoff M, McNellis D, Rocco L et al. Prevention of preeclampsia with low-dose aspirin in healthy, nulliparous pregnant women. N Engl J Med 1993;329:403-11.
7. Lê Thi Huong D, Wechsler B, Edelman P, Fournie A, Le Tallec Y, Piette JC et al. Postpartum cerebral infarction associated with aspirin withdrawal in the antiphospholipid syndrome. J Rheumatol 1993;20:1229-32.
8. Urowitz MB, Gladman DD, Farewell VT, Stewart J, McDonald J. Lupus and pregnancy studies. Arthritis Rheum 1993;36:1392-7.
9. Mintz G, Niz J, Guttierez G, Garcia-Alonso A, Karchmer S. Prospective study of pregnancy in systemic lupus erythematosus: results of a multidisciplinary approach. J Rheumatol 1986;13:732-9.
10. Petri M, Howard D, Repke J. Frequency of lupus flare in pregnancy. The Hopkins Lupus Pregnancy Center experience. Arthritis Rheum 1991;34:1538-45.
11. Wong KL, Chan FY, Lee CP. Outcome of pregnancy in patients with systemic lupus erythematosus. A prospective study. Arch Intern Med 1991;151:269-73.
12. Buyon JP, Cronstein BN, Morris M, Tanner M, Weissmann G. Serum complement values (C3 and C4) to differentiate between systemic lupus activity and preeclampsia. Am J Med 1986;81:194-200.
13. Buyon JP, Tamerius J, Ordorica S, Young B, Abramson SB. Activation of the alternative complement pathway accompanies disease flares in systemic lupus erythematosus during pregnancy. Arthritis Rheum 1992;35:55-61.
14. Nossent HC, Swaak TJG. Systemic lupus erythematosus. VI. Analysis of the interrelationship with pregnancy. J Rheumatol 1986;17:771-6.
15. Rubbert A, Pirner K, Wildt L, Kalden JR, Manger B. Pregnancy course and complications in patients with systemic lupus erythematosus. Am J Reprod Immunol 1992;28:205-7.
16. Shibata S, Sasaki T, Hirabayashi Y, Seino J, Okamura K, Yoshinaga K et al. Risk factors in the pregnancy of patients with systemic lupus erythematosus: association of hypocomplementemia with poor prognosis. Ann Rheum Dis 1992;51:619-23.
17. Lynch A, Malar R, Murphy J, Davila G, Santos M, Rutledge J et al. Antiphospholipid antibodies in predicting adverse pregnancy outcome. A prospective study. Ann Intern Med 1994;120:470-5.
18. Parke AL, Wilson D, Maier D. The prevalence of antiphospholipid antibodies in women with recurrent spontaneous abortion, women with successful pregnancies, and women who have never been pregnant. Arthritis Rheum 1991;34:1231-5.
19. Deleze M, Alarcon-Segovia D, Valdes-Macho E, Oria CV, Ponce de Leon S. Relationship between antiphospholipid antibodies and recurrent fetal loss in patients with systemic lupus erythematosus and apparently healthy women. J Rheumatol 1989;16:768-72.
20. Kutteh WH, Lyda EC, Abraham SM, Wacholtz MC. Association of anticardiolipin antibodies and pregnancy loss in women with systemic lupus erythematosus. Fertil Steril 1993;60:449-55.
21. Infante-Rivard C, David M, Gauthier R, Rivard G-E. Lupus anticoagulants, anticardiolipin antibodies, and fetal loss. A case-control study. N Engl J Med 1991;325:1063-6.
22. Out HJ, Bruinse HW, Christiaens GCML, van Vliet M, Meilof JF, de Groot PG et al. Prevalence of antiphospholipid antibodies in patients with fetal loss. Ann Rheum Dis 1991;50:553-7.
23. Lockshin MD, Qamar T, Druzin ML, Goei S. Antibody to cardiolipin, lupus anticoagulant, and fetal death. J Rheumatol 1987;14:259-62.
24. Petri M, Howard D, Repke J, Goldman DW. The Hopkins Lupus Pregnancy Center: 1987-1991 update. Am J Reprod Immunol 1992;28:188-91.
25. Branch DW, Silver RM, Blackwell JL, Reading JC, Scott JR. Outcome of treated pregnancies in women with antiphospholipid syndrome: an update of the Utah experience. Obstet Gynecol 1992;80:614-20.
26. Branch DW. Thoughts on the mechanism of pregnancy loss associated with the antiphospholipid syndrome. Lupus 1994;3:275-80.
27. Branch DW, Andres R, Digre KB, Rote NS, Scott JR. The association of antiphospholipid antibodies with severe pre-eclampsia. Obstet Gynecol 1989;73:541-5.
28. Sletnes KE, Wislott F, Moe N, Dale PO. Antiphospholipid antibodies in pre-eclamptic women: relation to growth retardation and neonatal outcome. Acta Obstet Gynecol Scand 1992;7:112-7.
29. Silveira LH, Hubble CL, Jara LJ, Saway S, Martinez-Osuna P, Seleznick MJ et al. Prevention of anticardiolipin antibody-related pregnancy losses with prednisone and aspirin. Am J Med 1992;93:403-11.
30. Hasegawa I, Takakuwa K, Goto S, Yamada K, Sekizuka N, Kanazawa K et al. Effectiveness of prednisolone/ aspirin therapy for recurrent aborters with antiphospholipid antibody. Hum Reprod 1992;7:203-7.
31. Cowchock FS, Reece EA, Balaban D, Branch DW, Plouffe L. Repeated fetal losses associated with antiphospholipid antibodies: a collaborative randomized trial comparing prednisone with low-dose heparin treatment. Am J Obstet Gynecol 1992;166:1318-23.
32. Sanchez-Guerrero J, Alarcon-Segovia D. Course of antiphospholipid antibodies in patients with primary antiphospholipid syndrome before, during and after pregnancy treated with low dose aspirin. Relationship of antibody levels to outcome in 7 patients. J Rheumatol 1992;19:1083-8.
33. Silver RK, McGregor DO, Sholl JS, Hobart JM, Neerhof DO, Ragin A. Comparative trial of prednisone plus aspirin versus aspirin alone in the treatment of anticardiolipin antibody-positive obstetric patient. Am J Obstet Gynecol 1993;169:1411-7.
34. Rosove MH, Tabsh K, Wasserstrum N, Howard P, Hahn BH, Kalunian KC. Heparin therapy for pregnant women with lupus anticoagulant or anticardiolipin antibodies. Obstet Gynecol 1990;75:630-4.
35. Park A, Maier D, Wilson D, Andreoli J, Ballow M. Intravenous gamma-globulin, antiphospholipid antibodies and pregnancy. Ann Intern Med 1989;110:495-6.
36. Kobayashi S, Tamura N, Tsuda H, Mokuno C, Hashimoto H, Hirose S. Immunoadsorbent plasmapheresis for a patient with antiphospholipid syndrome during pregnancy. Ann Rheum Dis 1992;51:399-401.
37. Rumeau-Rouquette C, du Mazaubrun C, Rabarison Y. Naitre en France. 10 ans d'évolution 1972-1981. Paris: INSERM, Doin Editeurs, 1984.
38. Ovasiu E, Hicks J, Cameron JS. The outcome of pregnancy in women with lupus nephritis. Lupus 1991;1:19-25.
39. Kitridou RC, Mintz G. Pregnancy in lupus: The mother in SLE. The fetus in SLE. In: Dubois EL, Wallace J, eds. Lupus erythematosus, 4th edn. London: Lea & Febiger, 1993:487-507, 508-15.
40. Johnson MJ, Petri M, Witter FR, Repke JT. Evaluation of preterm delivery in a systemic lupus erythematosus pregnancy clinic. Obstet Gynecol 1995;86:396-9.
41. Jungers P, Dougados M, Pelissier C, Kuttenn F, Tron F, Lesavre Ph et al. Lupus nephropathy and pregnancy: report of 104 cases in 36 patients. Arch Intern Med 1982;142:771-6.
42. Imbasciati E, Surian M, Bottino S et al. Lupus nephropathy and pregnancy. Nephron 1984;36:46-51.
43. Packham DK, Lam SS, Nicholls K, Fairley KF, Kincaid-Smith PS. Lupus nephritis and pregnancy. Q J Med 1992;300:315-24.
44. Ramsey-Goldman R, Kutzer JE, Kuller LH, Guzick D, Carpenter AB, Medsger TA. Previous pregnancy outcome is an important determinant to subsequent pregnancy outcome in women with systemic lupus erythematosus. Am J Reprod Immunol 1992;28:195-8.
45. Buyon JP, Yaron M, Lockshin MD. First International Conference on Rheumatic Diseases in Pregnancy. Arthritis Rheum 1993;36:59-64.
46. Olah KS, Gee H. Fetal heart block associated with maternal anti-Ro (SS-A) antibody - current management. A review. Br J Obstet Gynaecol 1991;98:751-5.
47. Provost TT, Watson R, Gammon WR, Radowsky M, Harley JB, Reichlin M. The neonatal lupus syndrome associated with U1 RNP (nRNP) antibodies. N Engl J Med 1987;316:1135-8.